James Black Foundation Limited
Records under this name other than patents James Black Foundation Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to James Black Foundation Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,479,531 | Gastrin and cholecystokinin receptor ligands Lapsed on the fee record Ended Nov 12, 2010 · USPTO record | Lapsed on the fee record | Ended Nov 12, 2010 | USPTO record |
| US 7,105,558 | Gastrin and cholecystokinin receptor lignads (iv) Lapsed on the fee record Ended Sep 12, 2010 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2010 | USPTO record |
| US 6,407,132 | Substituted imidazole derivatives and their use as histamine H3 receptor ligands Lapsed on the fee record Ended Jun 18, 2010 · USPTO record | Lapsed on the fee record | Ended Jun 18, 2010 | USPTO record |
| US 7,034,048 | Gastrin and cholecystokinin receptor ligands (III) Lapsed on the fee record Ended Apr 25, 2010 · USPTO record | Lapsed on the fee record | Ended Apr 25, 2010 | USPTO record |
| US 6,355,665 | 1H-4(5)-substituted imidazole derivatives, their preparation and their use as histamine H3 receptor ligands Lapsed on the fee record Ended Mar 12, 2010 · USPTO record | Lapsed on the fee record | Ended Mar 12, 2010 | USPTO record |
| US 6,956,053 | Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands Lapsed on the fee record Ended Oct 18, 2009 · USPTO record | Lapsed on the fee record | Ended Oct 18, 2009 | USPTO record |
| US 6,878,734 | Gastrin and cholecystokinin receptor ligands(II) Lapsed on the fee record Ended Apr 12, 2009 · USPTO record | Lapsed on the fee record | Ended Apr 12, 2009 | USPTO record |
| US 6,878,736 | Histamine H3 receptor ligands Lapsed on the fee record Ended Apr 12, 2009 · USPTO record | Lapsed on the fee record | Ended Apr 12, 2009 | USPTO record |
| US 6,159,994 | Histamine H.sub.3 receptor ligands Lapsed on the fee record Ended Dec 12, 2008 · USPTO record | Lapsed on the fee record | Ended Dec 12, 2008 | USPTO record |
| US 6,080,871 | Sulfonamides and sulfamides as H.sub.3 receptor antagonists Lapsed on the fee record Ended Jun 27, 2008 · USPTO record | Lapsed on the fee record | Ended Jun 27, 2008 | USPTO record |